Phenindione

Chemical structure of Phenindione

Phenindione is an anticoagulant medication that belongs to the class of vitamin K antagonists. It is used to prevent and treat thromboembolic disorders by inhibiting the synthesis of vitamin K-dependent clotting factors in the liver.

Mechanism of Action

Phenindione works by interfering with the vitamin K epoxide reductase complex, which is essential for the regeneration of vitamin K in its active form. This inhibition leads to a decrease in the synthesis of clotting factors II, VII, IX, and X, which are necessary for the coagulation cascade. As a result, the blood's ability to clot is reduced, helping to prevent the formation of blood clots.

Clinical Use

Phenindione is primarily used in the management of conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and the prevention of stroke in patients with atrial fibrillation. It is an alternative to other anticoagulants like warfarin and acenocoumarol.

Side Effects

The use of phenindione can lead to several side effects, including bleeding, which is the most significant risk associated with anticoagulant therapy. Other potential side effects include rash, fever, and liver dysfunction. Patients on phenindione require regular monitoring of their prothrombin time (PT) or international normalized ratio (INR) to ensure therapeutic levels are maintained and to minimize the risk of bleeding.

Contraindications

Phenindione is contraindicated in patients with active bleeding, severe liver disease, or pregnancy, due to the risk of teratogenicity. It should be used with caution in patients with a history of peptic ulcer disease or other conditions that predispose them to bleeding.

Related Pages

• Anticoagulant
• Vitamin K antagonist
• Warfarin
• Thromboembolism